Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen
Authors:
- Dong WangDWDong Wang
- Wei-Zhen WuWWWei-Zhen Wu
- Jian-Ming TanJTJian-Ming Tan
- 1 January 2008
- journal article
- research article
- Published by Elsevier in Transplant Immunology
- Vol. 18 (3) , 281-285
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- One Year Results of Preoperative Single Bolus ATG-Fresenius Induction Therapy in Sensitized Renal Transplant RecipientsTransplantation Proceedings, 2007
- Intravenous Gammaglobulin (IVIG): A Novel Approach to Improve Transplant Rates and Outcomes in Highly HLA-Sensitized PatientsAmerican Journal of Transplantation, 2006
- The Selective Use of Basiliximab Versus Thymoglobulin in Combination with Sirolimus for Cadaveric Renal Transplant Recipients at Low Risk Versus High Risk for Delayed Graft FunctionTransplantation, 2004
- The role of anti–IL-2 receptor in high-risk kidney transplant patientsTransplantation Proceedings, 2004
- Sequential Protocols using Basiliximab versus Anti-Thymocyte Globulins in Renal-Transplant Patients Receiving Mycophenolate Mofetil and SteroidsTransplantation, 2004
- National Conference to Assess Antibody-Mediated Rejection in Solid Organ TransplantationAmerican Journal of Transplantation, 2004
- Induction versus noninduction therapy in kidney transplantation: considering different PRA levels and different induction therapiesTransplantation Proceedings, 2004
- Predicting Kidney Graft Failure by HLA Antibodies: a Prospective TrialAmerican Journal of Transplantation, 2004
- Intraoperative anti-thymocyte globulin-fresenius (ATG-F) administration as induction immunosuppressive therapy in kidney transplantationMolecular Immunology, 2003
- Short and long-term results after pretransplant high-dose single ATG-fresenius bolus in cadaveric kidney transplantationTransplantation Proceedings, 1998